BMY Latest Headlines

TrumpRx launch now delayed - report

at seekingalpha.com (Thu, 29-Jan 1:53 PM)

Bristol-Myers Squibb Expands Real-World Evidence for Mavacamten in China: What Investors Should Know

at www.tipranks.com (Thu, 29-Jan 11:32 AM)

Analysts Are Bullish on These Healthcare Stocks: Bristol-Myers Squibb (BMY), HCA Healthcare (HCA)

at www.tipranks.com (Thu, 29-Jan 3:31 AM)

TrumpRx expected to launch on Friday: report

at seekingalpha.com (Wed, 28-Jan 1:13 PM)

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Bristol-Myers Squibb (BMY), HCA Healthcare (HCA) and Intuitive Surgical (ISRG)

at www.tipranks.com (Wed, 28-Jan 9:03 AM)

Pfizer, Novartis, Lilly drugs in latest round of Medicare drug price negotiations

at seekingalpha.com (Tue, 27-Jan 6:20 PM)

Healthcare lobbying efforts reach record high in Washington: report

at seekingalpha.com (Tue, 27-Jan 2:21 PM)

Bristol-Myers Squibb Advances Repotrectinib Interaction Study: What Investors Should Know

at www.tipranks.com (Mon, 26-Jan 11:32 AM)

Bristol Myers Squibb to Continue ADEPT-2 Phase 3 Alzheimer’s Psychosis Study After Data Committee Review

Market Chameleon (Wed, 3-Dec 7:31 AM)

Bristol Myers Squibb Plans Investor Event to Spotlight Hematology Strategy After ASH Meeting

Market Chameleon (Mon, 24-Nov 7:06 AM)

BMY Discontinues Librexia ACS Trial After Efficacy Review; Milvexian Still Central to Stroke and AF Research

Market Chameleon (Fri, 14-Nov 7:33 AM)

Bristol Myers Squibb Releases Q3 2025 Financial Results—Key Insights Ahead of Investor Call

Market Chameleon (Thu, 30-Oct 7:46 AM)